Pathway enrichment analysis indicated that Wnt11 may contribute to the biological processes of AML by interacting with genes involved in cell morphogenesis during differentiation, blood vessel development, hemostasis, and hematopoietic cell lineage. This evidence concerns the gene WNT11 and acute myeloid leukemia.